Patents by Inventor Bryan Kramer

Bryan Kramer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Mch receptor antagonists
    Publication number: 20070037836
    Abstract: The present invention relates to novel compounds of the formula (I) which act as MCH receptor antagonists. These compositions are useful in pharmaceutical compositions whose use includes prophylaxis or treatment of obesity, obesity related disorders, anxiety, or depression.
    Type: Application
    Filed: September 30, 2002
    Publication date: February 15, 2007
    Inventors: Yoshinori Sekiguchi, Kosuke Kanuma, Katsunori Omodera, Thuy-Anh Tran, Bryan Kramer, Nigel Beeley
  • Novel quinazoline derivatives and methods of treatment related to the use thereof
    Publication number: 20070010671
    Abstract: The present invention relates to novel compounds of Formula (1): which act as MCH receptor antagonists. These compositions are useful in pharmaceutical compositions whose use includes prophylaxis or treatment of improving memory function, sleeping and arousal, anxiety, depression, mood disorders, seizure, obesity, diabetes, appetite and eating disorders, cardiovascular disease, hypertension, dyslipidemia, myocardial infarction, binge eating disorders including bulimia, anorexia, mental disorders including manic depression, schizophrenia, delirium, dementia, stress, cognitive disorders, attention deficit disorder, substance abuse disorders and dyskinesias including Parkinson's disease, epilepsy, and addiction.
    Type: Application
    Filed: March 30, 2004
    Publication date: January 11, 2007
    Inventors: Yoshinori Sekiguchi, Kosuke Kanuma, Katsunori Omodera, Tsuyoshi Busujima, Thuy-Anh Tran, Sangdon Han, Martin Casper, Bryan Kramer
  • Novel quinoline, tetrahydroquinazoline, and pyrimidine derivatives and methods of treatment related to the use thereof
    Publication number: 20050197350
    Abstract: The present invention relates to novel compounds of the Formula (I): which act as MCH receptor antagonists. These compositions are useful in pharmaceutical compositions whose use includes prophylaxis or treatment of improving memory function, sleeping and arousal, anxiety, depression, mood disorders, seizure, obesity, diabetes, appetite and eating disorders, cardiovascular disease, hypertension, dyslipidemia, myocardial infarction, binge eating disorders including bulimia, anorexia, mental disorders including manic depression, schizophrenia, delirium, dementia, stress, cognitive disorders, attention deficit disorder, substance abuse disorders and dyskinesias including Parkinson's disease, epilepsy, and addiction.
    Type: Application
    Filed: March 30, 2004
    Publication date: September 8, 2005
    Inventors: Yoshinori Sekiguchi, Kosuke Kanuma, Katsunori Omodera, Tsuyoshi Busujima, Thuy-Anh Tran, Sangdon Han, Martin Casper, Bryan Kramer, Graeme Semple, Ning Zou